A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration

被引:35
作者
Cao, Xuan [1 ,2 ]
Kaneko, Tomonori [1 ]
Li, Jenny S. [3 ]
Liu, An-Dong [2 ]
Voss, Courtney [1 ]
Li, Shawn S. C. [1 ,4 ]
机构
[1] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada
[2] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Med Genet, Tongji Med Coll, Wuhan 430030, Peoples R China
[3] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, London, ON N6A 5C1, Canada
[4] Childrens Hlth Res Inst, London, ON N6C 2V5, Canada
来源
NATURE COMMUNICATIONS | 2015年 / 6卷
关键词
TUMOR-SUPPRESSOR PTEN; BREAST-CANCER CELLS; MEMBRANE ASSOCIATION; PHOSPHATASE-ACTIVITY; PROTEIN DLC-1; C2; DOMAINS; SH2; DOMAIN; RAC; GROWTH; EGF;
D O I
10.1038/ncomms8721
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although cell migration plays a central role in development and disease, the underlying molecular mechanism is not fully understood. Here we report that a phosphorylation-mediated molecular switch comprising deleted in liver cancer 1 (DLC1), tensin-3 (TNS3), phosphatase and tensin homologue (PTEN) and phosphoinositide-3-kinase (PI3K) controls the spatiotemporal activation of the small GTPases, Rac1 and RhoA, thereby initiating directional cell migration induced by growth factors. On epidermal growth factor (EGF) or platelet-derived growth factor (PDGF) stimulation, TNS3 and PTEN are phosphorylated at specific Thr residues, which trigger the rearrangement of the TNS3-DLC1 and PTEN-PI3K complexes into the TNS3-PI3K and PTEN-DLC1 complexes. Subsequently, the TNS3-PI3K complex translocates to the leading edge of a migrating cell to promote Rac1 activation, whereas PTEN-DLC1 translocates to the posterior for localized RhoA activation. Our work identifies a core signalling mechanism by which an external motility stimulus is coupled to the spatiotemporal activation of Rac1 and RhoA to drive directional cell migration.
引用
收藏
页数:14
相关论文
共 64 条
  • [1] Barber Mark A, 2006, Bull Cancer, V93, pE44
  • [2] Growth factors and cytokines in wound healing
    Barrientos, Stephan
    Stojadinovic, Olivera
    Golinko, Michael S.
    Brem, Harold
    Tomic-Canic, Marjana
    [J]. WOUND REPAIR AND REGENERATION, 2008, 16 (05) : 585 - 601
  • [3] The C2 domain of PKCδ is a phosphotyrosine binding domain
    Benes, CH
    Wu, N
    Elia, AEH
    Dharia, T
    Cantley, LC
    Soltoff, SP
    [J]. CELL, 2005, 121 (02) : 271 - 280
  • [4] GEFs and GAPs: Critical elements in the control of small G proteins
    Bos, Johannes L.
    Rehmann, Holger
    Wittinghofer, Alfred
    [J]. CELL, 2007, 129 (05) : 865 - 877
  • [5] Rho and Rac take center stage
    Burridge, K
    Wennerberg, K
    [J]. CELL, 2004, 116 (02) : 167 - 179
  • [6] New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway
    Cantley, LC
    Neel, BG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4240 - 4245
  • [7] Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation
    Cao, Xuan
    Voss, Courtney
    Zhao, Bing
    Kaneko, Tomonori
    Li, Shawn Shun-Cheng
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (05) : 1455 - 1460
  • [8] Membrane binding and subcellular targeting of C2 domains
    Cho, Wonhwa
    Stahelin, Robert V.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (08): : 838 - 849
  • [9] GDIs: central regulatory molecules in Rho GTPase activation
    DerMardirossian, C
    Bokoch, GM
    [J]. TRENDS IN CELL BIOLOGY, 2005, 15 (07) : 356 - 363
  • [10] Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth
    Durkin, M. E.
    Ullmannova, V.
    Guan, M.
    Popescu, N. C.
    [J]. ONCOGENE, 2007, 26 (31) : 4580 - 4589